Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE: Safety Overview

Metric DOLUTEGRAVIR DOLUTEGRAVIR\RILPIVIRINE
Total FAERS Reports 10,772 1,216
Deaths Reported 1,001 73
Death Rate 9.3% 6.0%
Hospitalizations 2,225 176
Average Patient Age 44.5 yrs 53.8 yrs
% Female Patients 42.1% 26.5%
FDA Approval Date Aug 12, 2013 N/A
Manufacturer ViiV Healthcare Company N/A
Route ORAL N/A
Marketing Status Prescription N/A